Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Вторичная профилактика сердечно-сосудистых осложнений в отдаленном периоде после хирургического лечения ишемической болезни сердца в условиях практического здравоохранения

E-mail: Сведения доступны для зарегистрированных пользователей.

Link: Clinical Physiology of Blood Circulaiton. 2011; (): -

Full text:  

Abstract

Questionnaire allowing one to evaluate the quality and main drawbacks of the treatment of IHD patients after cardiosurgical interventions was worked out. The quality of the treatment in the outpatient setting was stated inadequately efficient since only 57% of patients were under the care of a cardiologist, and 15% of patients were under the care of neither cardiologist nor the therapist. Low application frequency of drugs with established efficiency (statins, beta-blockers, etc.) and low rate of physicians' indications as well as observance of nonpharmacological measures to correct the life way (weight control, diet, cessation, etc.) were noted. It was shown that to improve the quality of the treatment it is essential to specialize the therapeutic approach to increase compliance with the therapy indicated and optimal adjustment of drug dosage.

References

Бенделиани, Н. Г. Соблюдение клинических рекомендаций врачами в общемедицинской практике и приверженность пациентов терапии как основа эффективного лечения / Н. Г. Бенделиани // Бюл. НЦССХ им. А. Н. Бакулева РАМН. - 2011. - Т. 12, № 1. - С. 48-57.
Бокерия, Л. А. Качество реализации медикаментозного лечения больных ИБС после кардиохирургических вмешательств в условиях реальной практики / Л. А. Бокерия, С. Ф. Никонов, Н. Г. Бенделиани, М. М. Алшибая // Бюл. НЦССХ им. А. Н. Бакулева РАМН. - 2010. - Т. 11, № 6. - С. 256.
A Guide to Atherothrombosis and The REACH Registry. - P. 1-20.
Antithrombotic Trialists Collaboration // BMJ. - 2002. - Vol. 324. - P. 71-86.
Steg, P. G. et al. // Am. J. Cardiol. - 2002. - Vol. 90, № 4. - P. 358-363.
Ohman, E. M. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design / E. M. Ohman, D. L. Bhatt, P. G. Steg et al. // Am. Heart J. - 2006. - Vol. 151, № 4. - P. 786.e1-786.e10.
Grundy, S. M. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines / S. M. Grundy, Cleeman, C. N. B. Merz // Circulation. - 2004. - Vol. 10. - P. 227-239.

 If you found mistakes, select text and press Alt+A